Reduced Arg-1 expression in PMN-MDSCs from tumor tissue in vivo, and reduced M-CSFR expression on human cord blood-derived MDSCs in vitro (30) suggest that icaritin may exert its anti-tumor activity via impairing the MDSCs through multiple mechanisms of action. This evidence concerns the gene ARG1 and neoplasm.